Chemomab Therapeutics Ltd - ADR

:ANCN  
17.03
+0.44 (+2.65%)
Mergers / Acquisitions

Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement

Published: 12/15/2020 14:33 GMT
(ANCN) - Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement.
Anchiano Therapeutics Ltd - Proposed Merger Will Create a Public Company Focused on Advancing Chemomab's Lead Product, Cm-101.
Anchiano Therapeutics Ltd - Entry Into Merger Agreement Pursuant to Which Shareholders of Chemomab Would Become Majority Holders of Combined Company.
Anchiano Therapeutics Ltd - Combined Company Will Assume Name "chemomab Therapeutics Ltd.
" and Will Be Led by Chemomab's Management.
Anchiano - Chemomab Shareholders, Holders of Chemomab Equity Awards Will Convert 100% of Existing Equity Interests Into Securities of Combined Company.